Renewed Talk of Biomet Merger
BY ARIELLA P. GOLOMB, MD, OCTOBER 24, 2006
Reuters reported that takeover speculation from the ft.com/alphaville website and trading desks were fueling bullish options trading of Biomet shares. The merger is speculated to involve a "larger company or possibly a private equity bid." Smith & Nephew has been named by some analysts as a likely acquirer given the portfolio fit and the size of the company.
As you may recall, back in April Biomet hired Morgan Stanley to "explore strategic alternatives focused on enhancing shareholder value", and there has been much change at the company this year. This merger would come at no surprise, as it has been predicted for quite some time.
